134 related articles for article (PubMed ID: 17993998)
1. Higher dose of statin medication may be better for older adults.
Mayo Clin Womens Healthsource; 2007 Dec; 11(12):3. PubMed ID: 17993998
[No Abstract] [Full Text] [Related]
2. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
[No Abstract] [Full Text] [Related]
3. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke].
Crisby M; Olsson AG
Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582
[No Abstract] [Full Text] [Related]
4. [High dosage stain protects heart and brain from recurrence].
MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
[No Abstract] [Full Text] [Related]
5. High-dose statins and the IDEAL study.
Mann SJ
JAMA; 2006 Jun; 295(21):2477-8; author reply 2478-9. PubMed ID: 16757715
[No Abstract] [Full Text] [Related]
6. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
Klose G
MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
[No Abstract] [Full Text] [Related]
7. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
van der Harst P; Voors AA; van Veldhuisen DJ
N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
[No Abstract] [Full Text] [Related]
8. [After TIA and stroke: a statin for secondary prevention?].
MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
[No Abstract] [Full Text] [Related]
9. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
Schwertz DW; Badellino KO
J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
11. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation.
Hong SJ; Choi SC; Kim JS; Shim WJ; Park SM; Ahn CM; Park JH; Kim YH; Lim DS
Heart; 2010 May; 96(10):756-64. PubMed ID: 20448126
[TBL] [Abstract][Full Text] [Related]
12. Intensive statin therapy--a sea change in cardiovascular prevention.
Topol EJ
N Engl J Med; 2004 Apr; 350(15):1562-4. PubMed ID: 15007111
[No Abstract] [Full Text] [Related]
13. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes.
Ferrer-García JC; Sanchez-Ballester E; Albalat-Galera R; Berzosa-Sanchez M; Herrera-Ballester A
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):183-8. PubMed ID: 18635754
[TBL] [Abstract][Full Text] [Related]
16. Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation.
Vasankari T; Ahotupa M; Viikari J; Nuotio I; Vuorenmaa T; Strandberg T; Vanhanen H; Tikkanen MJ
Atherosclerosis; 2005 Mar; 179(1):207-9. PubMed ID: 15721029
[No Abstract] [Full Text] [Related]
17. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
[TBL] [Abstract][Full Text] [Related]
18. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
19. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.
Leiter LA; Martineau P; de Teresa E; Farsang C; Gaw A; Gensini G; Langer A;
J Fam Pract; 2008 Oct; 57(10):661-8. PubMed ID: 18842192
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.
Katsiki N; Athyros VG; Karagiannis A
Curr Med Res Opin; 2014 Jan; 30(1):55. PubMed ID: 24024869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
